Tech Company Financing Transactions

Relypsa Funding Round

Relypsa closed a $70 million Series B venture capital round on 9/13/2010. Investors included 5AM Ventures, Delphi Ventures and New Leaf Venture Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

700 Saginaw Drive
Redwood City, CA 94063
USA

Phone

650.421.9500

Website

www.relypsa.com

Email Address

[email protected]

Overview

Relypsa, Inc. is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Orwin

        

Chief Financial Officer

Kristine Ball

        

VP - General Counsel

Ronald Krasnow

        

VP - Human Resources

Mary Corbett

        

VP - Regulatory Affairs

Claire Lockey

        

Browse more venture capital transactions:

Prev: 9/13/2010: Company.com venture capital transaction
Next: 9/13/2010: Hemoshear venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary